Similarly, we found that RNASEH2A is highly expressed in cervical cancer and participates in RNA catabolic process, which is expected to become a molecular diagnostic marker and therapeutic target of cervical cancer. The gene discussed is RNASEH2A; the disease is cervical carcinoma.